These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32726914)

  • 41. Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon.
    Chiampanichayakul S; Kataoka K; Arimochi H; Thumvijit S; Kuwahara T; Nakayama H; Vinitketkumnuen U; Ohnishi Y
    J Med Invest; 2001 Feb; 48(1-2):88-96. PubMed ID: 11286022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bitter Melon (
    Mahwish ; Saeed F; Sultan MT; Riaz A; Ahmed S; Bigiu N; Amarowicz R; Manea R
    Plants (Basel); 2021 Apr; 10(4):. PubMed ID: 33918062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of a soluble phosphatidic acid phosphatase in bitter melon (Momordica charantia).
    Cao H; Sethumadhavan K; Grimm CC; Ullah AH
    PLoS One; 2014; 9(9):e106403. PubMed ID: 25203006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genome-Wide Analysis of Simple Sequence Repeats in Bitter Gourd (
    Cui J; Cheng J; Nong D; Peng J; Hu Y; He W; Zhou Q; Dhillon NPS; Hu K
    Front Plant Sci; 2017; 8():1103. PubMed ID: 28690629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis.
    Ray RB; Raychoudhuri A; Steele R; Nerurkar P
    Cancer Res; 2010 Mar; 70(5):1925-31. PubMed ID: 20179194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial activity and agricultural properties of bitter melon (Momordica charantia L.) grown in northern parts of Turkey: a case study for adaptation.
    Yaldız G; Sekeroglu N; Kulak M; Demirkol G
    Nat Prod Res; 2015; 29(6):543-5. PubMed ID: 25141891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Three Selected Edible Crops of the Genus
    Muronga M; Quispe C; Tshikhudo PP; Msagati TAM; Mudau FN; Martorell M; Salehi B; Abdull Razis AF; Sunusi U; Kamal RM; Sharifi-Rad J
    Front Pharmacol; 2021; 12():625546. PubMed ID: 34054516
    [No Abstract]   [Full Text] [Related]  

  • 48. Transcriptome and metabolome changes induced by bitter melon (
    Reed D; Kumar D; Kumar S; Raina K; Punia R; Kant R; Saba L; Cruickshank-Quinn C; Tabakoff B; Reisdorph N; Edwards MG; Wempe M; Agarwal C; Agarwal R
    J Tradit Complement Med; 2022 May; 12(3):287-301. PubMed ID: 35493312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolome Revealed the Potential Mechanism of Fusarium Wilt Resistance in Bitter Gourd (
    Guan F; Shi B; Zhang J; Wan X
    Plant Dis; 2024 Apr; 108(4):920-929. PubMed ID: 37814516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Telomere-to-telomere genome assembly of bitter melon (
    Fu A; Zheng Y; Guo J; Grierson D; Zhao X; Wen C; Liu Y; Li J; Zhang X; Yu Y; Ma H; Wang Q; Zuo J
    Hortic Res; 2023; 10(1):uhac228. PubMed ID: 36643758
    [No Abstract]   [Full Text] [Related]  

  • 51. Bitter Melon Extract Yields Multiple Effects on Intestinal Epithelial Cells and Likely Contributes to Anti-diabetic Functions.
    Chang CI; Cheng SY; Nurlatifah AO; Sung WW; Tu JH; Lee LL; Cheng HL
    Int J Med Sci; 2021; 18(8):1848-1856. PubMed ID: 33746602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mining the bitter melon (momordica charantia l.) seed transcriptome by 454 analysis of non-normalized and normalized cDNA populations for conjugated fatty acid metabolism-related genes.
    Yang P; Li X; Shipp MJ; Shockey JM; Cahoon EB
    BMC Plant Biol; 2010 Nov; 10():250. PubMed ID: 21080948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accumulation of Charantin and Expression of Triterpenoid Biosynthesis Genes in Bitter Melon (Momordica charantia).
    Cuong DM; Jeon J; Morgan AMA; Kim C; Kim JK; Lee SY; Park SU
    J Agric Food Chem; 2017 Aug; 65(33):7240-7249. PubMed ID: 28737900
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    Peeran SW; Murugan M; Fageeh H; Ibrahim W; Al-Ak'hali MS; Basheer SN; Mohamed AMB
    J Pharm Bioallied Sci; 2024 Apr; 16(Suppl 2):S1554-S1564. PubMed ID: 38882883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determination of the volatile chemical profile of
    Ferreira Almeida N; Dos Santos Niculau E; Cordeiro Toledo Lima P; Ferreira da Silva W
    Nat Prod Res; 2024 Mar; ():1-8. PubMed ID: 38440938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation of Biological Activities of Wild Bitter Melon (
    Pham TMH; Ngo DH; Ngo DN; Vo TS
    Biomolecules; 2019 May; 9(6):. PubMed ID: 31151277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening, discovery, and characterization of angiotensin-I converting enzyme inhibitory peptides derived from proteolytic hydrolysate of bitter melon seed proteins.
    Priyanto AD; Doerksen RJ; Chang CI; Sung WC; Widjanarko SB; Kusnadi J; Lin YC; Wang TC; Hsu JL
    J Proteomics; 2015 Oct; 128():424-35. PubMed ID: 26344130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial.
    Soo May L; Sanip Z; Ahmed Shokri A; Abdul Kadir A; Md Lazin MR
    Complement Ther Clin Pract; 2018 Aug; 32():181-186. PubMed ID: 30057048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Butanol Fraction of Bitter Melon (Momordica charantia) Scavenges Free Radicals and Attenuates Oxidative Stress.
    Kim HY; Sin SM; Lee S; Cho KM; Cho EJ
    Prev Nutr Food Sci; 2013 Mar; 18(1):18-22. PubMed ID: 24471105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The cytotoxic and cytostatic effects of the bitter melon (Momordica charantia) on human lymphocytes.
    Takemoto DJ; Dunford C; McMurray MM
    Toxicon; 1982; 20(3):593-9. PubMed ID: 7201686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.